Bryan Wahl

TARS

Bryan Wahl serves as General Counsel at Tarsus Pharmaceuticals, Inc. (TARS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$463.8K

Net Position

Net Seller

$463.8K

Companies Traded

TARS

Active Period

Mar 2025

1 total trades

Most Recent

Sell TARS

Mar 18, 2025 · $463.8K

Bryan Wahl's Insider Trading at Tarsus Pharmaceuticals, Inc. (TARS)

Buys

0 · $0.00

Sells

1 · $463.8K

Total Shares Bought

Total Shares Sold

9,686

TARS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 18, 2025↗	Sell	9,686	$47.88	$463.8K	0

Related Insiders

Seshadri Neervannan

officer: Chief Operating Officer

TARSSell · Mar 4, 2026

Dianne C. Whitfield

officer: Chief Human Resources Officer

TARSSell · Jan 2, 2026

Dianne C. Whitfield

Chief Human Resources Officer

TARSSell · Jan 2, 2026

Bobak R. Azamian

President/CEO and Board Chair

TARSSell · Dec 24, 2025

Elizabeth Yeu Lin

Chief Medical Officer

TARSSell · Dec 16, 2025

LINK WILLIAM J PHD

Director

TARSSell · Dec 15, 2025

Jeffrey S Farrow

See Remarks

TARSSell · Jun 17, 2025

Aziz Mottiwala

Chief Commercial Officer

TARSSell · Jun 9, 2025

Explore More Insider Trading Data

TARS Insider Trading Activity

View all insider trades at Tarsus Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity